Taking the pneumococcal vaccine twice within two years is dangerous for older adults
the verdict
REFUTED
the evidence says no
confidence 4/100
Evidence shows that taking pneumococcal vaccines or revaccinations within short or recommended intervals is safe for older adults, with only mild and self-limiting side effects, contradicting the claim that doing so is dangerous.
Evidence against · 3
Vaccination in Multiple Myeloma: Challenges and Strategies.
2025 · cited by 3
Studies on sequential pneumococcal administration and high-risk populations indicate that recommended multi-dose regimens are well-tolerated and clinically beneficial rather than dangerous.
See more details
More against · 2
Immunogenicity and safety study of 23-valent pneumococcal polysaccharide vaccine revaccination among elderly individuals aged 60-70 years in Shanghai, China.
2025 · cited by 2
Clinical safety data on elderly adults revaccinated with PPSV23 show that adverse events are mild, self-limiting, and have lower overall incidence rates compared to first-time vaccination.
IAPSM's Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India.
2024 · cited by 0
Current guidelines for adult pneumococcal immunization note that the vaccines have minimal side effects and are well tolerated when administered according to schedule.